Joerg Reinhardt, Ph.D., is Chairman of the Board of Trustees of the Novartis Foundation. He is also Chairman of the Board of Directors of Novartis.
Ann Aerts has been leading the Novartis Foundation since 2013. Her and her team's work focus on improving urban heart health and narrowing health inequities through data- and digital-led population health approaches.
Dr. Jo Ivey Boufford is an expert in urban health, disease prevention, healthy aging, health promotion and health disparities.
Lutz Hegemann leads the Novartis Global Health unit and is responsible for integrating environmental, social and governance (ESG) matters into the core of the company’s business, with a special emphasis on innovation and access.
John is a proven data-driven leader with nearly four decades of data science, worldwide business, and technology transformation experience across Microsoft and IBM.
Peter Piot MD PhD is the Handa Professor of Global Health and former Director of the London School of Hygiene & Tropical Medicine.
Andreas von Planta is a leading expert in corporate governance, corporate law and stock exchange regulation. He advises boards of public companies on corporate governance matters and is a sought-after speaker and writer on these topics.